Brief: Gujarat Themis Biosyn Signs Definitive Agreement To Buy Microbiopharm Japan
22/05/2026 16:34
May 22 (Reuters) - Gujarat Themis Biosyn Ltd GTHM.NS: SIGNS DEFINITIVE AGREEMENT TO BUY MICROBIOPHARM JAPAN DEAL CONSIDERATION ABOUT JPY 21.5 BILLION (13 BILLION RUPEES) Source text: ID:nBSE7BLGbP Further company coverage: GTHM.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Gujarat Themis Biosyn
See all newsBrief: Gujarat Themis Biosyn Approves Issuance Of NCDs Up To 5.85 Billion Rupees On Private Placement Basis
Brief: Gujarat Themis Biosyn Board To Consider Fund Raising Via Non-Convertible Debentures On Sept 10
Brief: Gujarat Themis Biosyn To Issue Shares Worth Up To 3.35 Billion Rupees
Brief: Gujarat Themis Biosyn Approves Closure Of QIP Issue Period On August 28, 2026
Brief: Gujarat Themis Biosyn Initiates Arbitration Proceeding Against Optimus Drugs